Contact isolation precautions for ambulatory oncology patients positive for antibiotic resistant organisms a review of clinical effectiveness and guidelines

When providing ambulatory care to oncology patients that are known to be infected or colonized with antibiotic resistant organisms (AROs), it is important that adequate precaution be taken to reduce transmission risk. It is unclear, however, if Standard Precautions are sufficient or whether addition...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2 October 2015, 2015
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:When providing ambulatory care to oncology patients that are known to be infected or colonized with antibiotic resistant organisms (AROs), it is important that adequate precaution be taken to reduce transmission risk. It is unclear, however, if Standard Precautions are sufficient or whether additional precautions, such as Contact Precautions are required. Contact Precautions may include prioritizing placement of the patient into an exam room, use of additional personal protective equipment, additional hand hygiene, and other precautions that extend beyond Standard Precautions. This report sought to review the current literature evaluating the effectiveness of contact isolation precautions versus routine infection prevention practices for ambulatory oncology patients infected or colonized with AROs and evidence-based guidelines regarding the use of contact isolation precautions for ambulatory oncology patients infected or colonized with AROs
Item Description:"CADTH Rapid Response Service."
Physical Description:1 PDF file (7 pages) illustrations